Roccatagliata G, Pizio N, Farinini D, Firpo M P, Bartolini A, Bacigalupo F, Albano C
Rev Neurol (Paris). 1983;139(10):589-92.
Serotoninergic function has been evaluated in 15 H.C. patients. Therapeutic results obtained with an inhibitor of 5 HT reuptake (Fenfluramine) were evaluated in comparison to the effects of L-5HTP, CSF-5HIAA measurements were performed is each case before and after treatment. The pathological role of 5HT impairment in H. C. can not be excluded by the behavioral effects and CSF-5HIAA modifications that were observed.